Home » Topics » BioWorld Science

BioWorld Science
RSS

Primary and key secondary endpoints met in pivotal phase III trial of dasiglucagon

Sep. 19, 2018

Preclinical data presented for PIN-201104 as asthma therapy

Sep. 19, 2018

Ono collaborates with Fate Therapeutics on iPSC-derived CAR-T cell cancer therapies

Sep. 19, 2018

Ilumetri receives approval in Europe for treatment of moderate to severe chronic plaque psoriasis

Sep. 19, 2018

Galectin-3 concentration in bronchial tissue and BAL correlates with asthma severity

Sep. 19, 2018

GamaMabs Pharma initiates phase II study of GM-102 in patients with colorectal cancer

Sep. 19, 2018

Virion Biotherapeutics builds team to guide focus on respiratory virus infection management

Sep. 19, 2018

Zika and testosterone don't mix

Sep. 19, 2018

CRISPR plus unusual cell line give insight into rare BRCA variants

Sep. 19, 2018

Tumor oxygen boost improves radiation response

Sep. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...